GlassScriptPhysician profile
Vikas K Agrawal
NPI 1568523496
$5,061.65
in general payments reported to CMS, 2019-2025
39 companies · $612 in 2025
The $612 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $881 · 2020: $214 · 2021: $612 · 2022: $971 · 2023: $888 · 2024: $884 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,371 · Education: $12.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,370.78 |
| Education | $12.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,136.04 | 2021-2025 | Qulipta, Ubrelvy |
| Emd Serono, INC. | $390.34 | 2019-2025 | Mavenclad |
| Sk Life Science, INC. | $332.17 | 2021-2025 | Xcopri |
| Lilly USA, LLC | $300.45 | 2019-2025 | Kisunla, Amyvid |
| Genzyme Corporation | $300.38 | 2019-2023 | |
| Alexion Pharmaceuticals, INC. | $269.35 | 2019-2024 | Ultomiris |
| Avanir Pharmaceuticals, INC. | $195.54 | 2019 | |
| Celgene Corporation | $190.39 | 2021-2025 | Zeposia |
| Boston Scientific Corporation | $180.72 | 2019-2025 | Intracept |
| Pfizer INC. | $168.27 | 2021-2024 | |
| Allergan, INC. | $157.83 | 2019-2020 | |
| Lundbeck LLC | $157.20 | 2021-2025 | Vyepti |
| Medtronic, INC. | $126.38 | 2021-2023 | Percept PC Brainsense |
| Supernus Pharmaceuticals, INC. | $116.71 | 2019 | |
| Novartis Pharmaceuticals Corporation | $110.22 | 2019-2023 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Agrawal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.